Engel Susan E, Director of Wells Fargo & Company (NYSE:WFC), unloaded 1,964 shares at an average price of $54.27 on December 10, 2014. The total amount of the transaction was worth $106,586, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing. On Friday shares of Wells Fargo & Company (NYSE:WFC) closed at $52.68. Company’s sales growth for last 5 years was 6.20% and EPS growth for next 5 years is recorded as 9.38%.
Celanese Corporation (NYSE:CE) currently carries a Zacks Rank #2 (Buy). Celanese Corporation (NYSE:CE) in last trading activity decreased -1.21% to close at $58.21. Company weekly performance is -2.97% while its quarterly performance stands at 8.84%. Celanese Corporation (NYSE:CE) is -11.50% away from its 52 week high.
Zacks upgraded shares of OFS Capital Corp from a neutral rating to an outperform rating. Zacks now has a $12.80 price target on that stock. On last trading day OFS Capital Corporation (NASDAQ:OFS) decreased -0.66% to close at $11.97. Its volatility for the week is 2.37% while volatility for the month is 2.76%. OFS’s EPS growth for past 5 years was 0.00%. OFS Capital Corporation (NASDAQ:OFS) monthly performance is 1.10%.
RCS Capital Corporation (NYSE:RCAP) reported that its wholesale broker dealer subsidiaries, Realty Capital Securities, LLC, , SC Distributors and The Hatteras Funds, lifted $9.7B for calendar year 2014, maintaining its leading market share for non-traded investment programs. The firm also reported that it lifted $270M in the month of December, exceeding anticipations, and that it is seeing steady improvement in sales across its platform. RCS Capital Corporation (NYSE:RCAP) has 1.60% insider ownership while its institutional ownership stands at 57.40%. In last trading activity company’s stock closed at $11.21.
According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the Director of Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL), Friedman Paul A had sold 29,689 shares worth of $1,001,410 in a transaction dated December 5, 2014. In this transaction, 29,689 shares were sold at $33.73 per share. On last trading day Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) decreased -0.33% to close at $36.51. Its volatility for the week is 2.46% while volatility for the month is 2.12%. AUXL’s sales growth for past 5 years was 26.20% and its EPS growth for past 5 years was 19.90%. Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) monthly performance is 6.97%.